Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials.
Badve SV, Bilal A, Lee MMY, Sattar N, Gerstein HC, Ruff CT, McMurray JJV, Rossing P, Bakris G, Mahaffey KW, Mann JFE, Colhoun HM, Tuttle KR, Pratley RE, Perkovic V.
Badve SV, et al. Among authors: lee mmy.
Lancet Diabetes Endocrinol. 2024 Nov 25:S2213-8587(24)00271-7. doi: 10.1016/S2213-8587(24)00271-7. Online ahead of print.
Lancet Diabetes Endocrinol. 2024.
PMID: 39608381